Literature DB >> 19018529

11C-Acetate PET imaging for renal cell carcinoma.

Nobuyuki Oyama1, Hidehiko Okazawa, Naoya Kusukawa, Taisei Kaneda, Yoshiji Miwa, Hironobu Akino, Yasuhisa Fujibayashi, Yoshiharu Yonekura, Michael J Welch, Osamu Yokoyama.   

Abstract

PURPOSE: In this study, we investigated the effectiveness of positron emission tomography (PET) with (11)C-acetate (AC) for evaluation of renal cell carcinoma.
METHODS: Enrolled in the study were 20 patients with suspected renal tumour, one of whom had three renal lesions. In all, 22 renal lesions were evaluated. Following administration of 350 MBq (10 mCi) of AC, whole-body PET images were obtained. Based on these PET findings, kidney lesions were scored as positive or negative. The PET results were correlated with the CT findings and histological diagnosis after surgery.
RESULTS: In 18 patients, 20 tumours were diagnosed as renal cell carcinoma. Lesions in the remaining two patients were diagnosed as complicated cyst without malignant tissue. Of the 20 renal cell carcinomas. 14 (70%) showed positive AC PET findings; 6 were negative. The two patients with complicated cyst had negative AC PET findings. Of the 20 renal cell carcinomas, 19 were clear-cell carcinoma and 1 was a papillary cell carcinoma. This papillary cell carcinoma showed high AC uptake.
CONCLUSION: AC demonstrates marked uptake in renal cell carcinoma. These preliminary data show that AC is a possible PET tracer for detection of renal cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19018529     DOI: 10.1007/s00259-008-0981-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  8 in total

Review 1.  The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies.

Authors:  M A Bosniak
Journal:  Radiology       Date:  1991-05       Impact factor: 11.105

2.  Small (< or = 3-cm) renal masses: detection with CT versus US and pathologic correlation.

Authors:  C A Jamis-Dow; P L Choyke; S B Jennings; W M Linehan; K N Thakore; M M Walther
Journal:  Radiology       Date:  1996-03       Impact factor: 11.105

3.  11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.

Authors:  Nobuyuki Oyama; Tom R Miller; Farrokh Dehdashti; Barry A Siegel; Keith C Fischer; Jeff M Michalski; Adam S Kibel; Gerald L Andriole; Joel Picus; Michael J Welch
Journal:  J Nucl Med       Date:  2003-04       Impact factor: 10.057

4.  [1-(11)C]acetate uptake is not increased in renal cell carcinoma.

Authors:  J Kotzerke; C Linné; M Meinhardt; J Steinbach; M Wirth; G Baretton; N Abolmaali; B Beuthien-Baumann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-30       Impact factor: 9.236

5.  11C-acetate PET imaging of prostate cancer.

Authors:  Nobuyuki Oyama; Hironobu Akino; Hiroshi Kanamaru; Yuji Suzuki; Satoshi Muramoto; Yoshiharu Yonekura; Norihiro Sadato; Kazutaka Yamamoto; Kenichiro Okada
Journal:  J Nucl Med       Date:  2002-02       Impact factor: 10.057

Review 6.  Current status of imaging indeterminate renal masses.

Authors:  D S Hartman; S Aronson; H Frazer
Journal:  Radiol Clin North Am       Date:  1991-05       Impact factor: 2.303

7.  The current radiological approach to renal cysts.

Authors:  M A Bosniak
Journal:  Radiology       Date:  1986-01       Impact factor: 11.105

8.  Carbon-11-acetate PET imaging in renal disease.

Authors:  P Shreve; P C Chiao; H D Humes; M Schwaiger; M D Gross
Journal:  J Nucl Med       Date:  1995-09       Impact factor: 10.057

  8 in total
  14 in total

Review 1.  Functional imaging of renal cell carcinoma.

Authors:  Nathan Lawrentschuk; Ian D Davis; Damien M Bolton; Andrew M Scott
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

2.  Assessment of Therapeutic Effect of Sunitinib by (11)C-Acetate PET Compared with FDG PET Imaging in a Patient with Metastatic Renal Cell Carcinoma.

Authors:  Nobuyuki Oyama; Noriko Takahara; Yoko Hasegawa; Kazuya Tanase; Yoshiji Miwa; Hironobu Akino; Hidehiko Okazawa; Takashi Kudo; Yasuhisa Fujibayashi; Osamu Yokoyama
Journal:  Nucl Med Mol Imaging       Date:  2011-05-20

Review 3.  Molecular imaging of the kidneys.

Authors:  Zsolt Szabo; Nada Alachkar; Jinsong Xia; William B Mathews; Hamid Rabb
Journal:  Semin Nucl Med       Date:  2011-01       Impact factor: 4.446

Review 4.  Nuclear imaging of renal tumours: a step towards improved risk stratification.

Authors:  Michael A Gorin; Steven P Rowe; Mohamad E Allaf
Journal:  Nat Rev Urol       Date:  2015-06-09       Impact factor: 14.432

5.  Chemical reaction-induced multi-molecular polarization (CRIMP).

Authors:  Y Lee; N M Zacharias; D Piwnica-Worms; P K Bhattacharya
Journal:  Chem Commun (Camb)       Date:  2014-11-07       Impact factor: 6.222

6.  The clinical use of PET with (11)C-acetate.

Authors:  Ilaria Grassi; Cristina Nanni; Vincenzo Allegri; Joshua James Morigi; Gian Carlo Montini; Paolo Castellucci; Stefano Fanti
Journal:  Am J Nucl Med Mol Imaging       Date:  2011-12-15

7.  Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome.

Authors:  Yukie Yoshii; Takako Furukawa; Nobuyuki Oyama; Yoko Hasegawa; Yasushi Kiyono; Ryuichi Nishii; Atsuo Waki; Atsushi B Tsuji; Chizuru Sogawa; Hidekatsu Wakizaka; Toshimitsu Fukumura; Hiroshi Yoshii; Yasuhisa Fujibayashi; Jason S Lewis; Tsuneo Saga
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

Review 8.  The metabolic fate of acetate in cancer.

Authors:  Zachary T Schug; Johan Vande Voorde; Eyal Gottlieb
Journal:  Nat Rev Cancer       Date:  2016-08-26       Impact factor: 60.716

9.  Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer.

Authors:  Marc C Smaldone; David Yt Chen; Jian Q Yu; Elizabeth R Plimack
Journal:  Biologics       Date:  2012-11-19

10.  Fluorodeoxyglucose positron emission tomography-computed tomography scan in von Hippel-Lindau syndrome: A case report and review of literature.

Authors:  Shrikant Solav; Ritu Bhandari
Journal:  Indian J Nucl Med       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.